Basics of Biologics and Biosimilars An important factor when looking to market a biosimilar in the US is the patent dance. In this […]

Patent offices and courts have introduced proactive measures in response to the COVID-19 lockdown The COVID-19 pandemic, one of the biggest public health […]

On November 18, 2019, the Delhi High Court in the case of Merck Sharp & Dohme Corp & Anr v. Sanjeev Gupta & Ors passed […]

“Inventors do not invent for financial gain, they invent simply because they love to invent”. Isn’t it true? With this in mind, we […]

Often at times, a question that is frequently asked by individuals/startups while filing the patent application is “Which entity type should I file […]

Patent of Addition is a cost effective intellectual property weapon used for protecting the improvements or minor modifications taking place in the existing patent […]

Artificial Intelligence (AI) is a robot or machine that thinks like humans and mimics actions of human cognition such as speech, perception, vision, and even decision making. AI […]

On 9 April 2020, the Cancer Patients Aid Association (CPAA) a charitable organisation has written to Central Government for the revocation of recently […]

In US, Patent law offers two options for continuing an application, based on the parent non-provisional patent application. They are 1. Filing a […]

Some applicants file a provisional application to secure the earliest priority date for their invention, following it with a non-provisional application within 12 […]